A Michigan Medicine-led study published in Obstetrics & Gynecology evaluated 2,674 births at U-M Health Von Voigtlander Women's Hospital following a protocol change that doubled third-stage labor oxytocin from 30 to 60 units. Overall postpartum hemorrhage fell from 14.3% to 11.2%, driven by an approximate 40% relative reduction during vaginal births, along with decreased blood loss and reduced use of additional bleeding medications. No significant reduction occurred in cesarean births.
Impact on postpartum hemorrhage and blood loss
- ▪Among patients undergoing vaginal childbirth at U-M Health, implementation of the high-dose oxytocin protocol achieved an approximate 40% relative reduction in postpartum hemorrhage.
- ▪A Michigan Medicine study published in Obstetrics & Gynecology evaluated 2,674 births and found that implementing a high-dose oxytocin protocol reduced overall postpartum hemorrhage rates from 14.3% to 11.2%.
- ▪The high-dose oxytocin protocol at U-M Health Von Voigtlander Women's Hospital resulted in lower overall maternal blood loss and reduced the need for secondary medications to control bleeding.
- ▪The Michigan Medicine evaluation of 2,674 births found no statistically significant reduction in postpartum hemorrhage rates among patients delivering via cesarean section.
High-dose protocol implementation and dosage details
- ▪Implementation of the U-M Health high-dose oxytocin protocol required updating hospital medication orders, reconfiguring infusion pumps, and conducting staff education and training.
- ▪A quality improvement initiative at University of Michigan Health Von Voigtlander Women's Hospital doubled the postpartum oxytocin dose administered during the first hour after childbirth from 30 units to 60 units.
Need for further research on oxytocin dosing
- ▪Researchers emphasized that further clinical studies are necessary to evaluate the safety profile and dosage optimization of high-dose oxytocin across different modes of delivery.
- ▪Researchers comparing outcomes at U-M Health between January 1 and July 6, 2024 noted the necessity of ongoing research into evidence-based approaches for managing obstetric complications.
- ▪Lead author Dr. Jourdan Triebwasser stated that additional research is required to confirm the therapeutic benefits of high-dose oxytocin protocols across diverse clinical settings.
- ▪Although oxytocin is routinely administered to promote uterine contraction after childbirth, researchers noted that the optimal dosage and administration protocol remain under active investigation.
Story comments
Loading comments…